# PANTOPRAZOLE SODIUM
> **ANDA216171** · Abbreviated New Drug Application (Generic) · Sponsor: BE PHARMS · Approved 2022-05-18
## Drug
- **FDA Application Number:** ANDA216171
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PANTOPRAZOLE SODIUM
- **Generic name:** PANTOPRAZOLE SODIUM
- **Active ingredients:** PANTOPRAZOLE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BE PHARMS
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2022-05-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216171)
---
*AI Analytics · CC0 1.0*